REGN Capital Expenditure
Regeneron Pharmaceuticals · Capital Expenditure
REGN Capital Expenditure
Latest reported-$920.90Mperiod ending
REGN CapEx (-$1.00M → -$920.90M)
Annual CapEx
High-resolution chart · PNG
REGN capital expenditure history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -898,400,000 | |
| -755,900,000 | |
| -926,400,000 | |
| -590,100,000 | |
| -551,900,000 | |
| -614,600,000 | |
| -429,600,000 | |
| -383,100,000 | |
| -272,600,000 | |
| -511,900,000 | |
| -677,933,000 | |
| -333,006,000 | |
| -156,323,000 | |
| -49,337,000 | |
| -57,217,000 | |
| -99,689,000 | |
| -97,318,000 | |
| -34,857,000 | |
| -18,446,000 | |
| -2,811,000 | |
| -4,964,000 | |
| -6,174,000 | |
| -29,656,000 | |
| -34,370,000 | |
| -8,223,000 | |
| -6,495,000 | |
| -5,700,000 | |
| -3,000,000 | |
| -2,100,000 | |
| -8,600,000 | |
| -3,300,000 | |
| -6,900,000 | |
| -10,200,000 | |
| -2,100,000 | |
| -1,000,000 |